These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 19926248)
1. [Management of congenital toxoplasmosis in France: current data]. Garcia-Méric P; Franck J; Dumon H; Piarroux R Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248 [TBL] [Abstract][Full Text] [Related]
2. [Toxoplasma infections in early pregnancy: consequences and management]. Wallon M; Gaucherand P; Al Kurdi M; Peyron F J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis. Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865 [TBL] [Abstract][Full Text] [Related]
4. [Prevention of congenital toxoplasmosis]. Russo M; Galanti B Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535 [TBL] [Abstract][Full Text] [Related]
5. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF. Picone O; Fuchs F; Benoist G; Binquet C; Kieffer F; Wallon M; Wehbe K; Mandelbrot L; Villena I J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101814. PubMed ID: 32428782 [TBL] [Abstract][Full Text] [Related]
6. [Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management]. Di Carlo P; Mazzola A; Romano A; Schimmenti MG; Colicchia P; Bellipanni P; Titone L Infez Med; 2005 Jun; 13(2):72-8. PubMed ID: 16220026 [TBL] [Abstract][Full Text] [Related]
7. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R; Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of mother-to-child transmission of toxoplasmosis: perspectives]. Mandelbrot L Gynecol Obstet Fertil; 2012 Oct; 40(10):591-8. PubMed ID: 22981973 [TBL] [Abstract][Full Text] [Related]
10. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Brézin AP; Thulliez P; Couvreur J; Nobré R; Mcleod R; Mets MB Am J Ophthalmol; 2003 Jun; 135(6):779-84. PubMed ID: 12788116 [TBL] [Abstract][Full Text] [Related]
11. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824 [TBL] [Abstract][Full Text] [Related]
12. [Prevention and treatment of materno-fetal toxoplasmosis]. Fortier B; Ajana F; Pinto de Sousa MI; Aissi E; Camus D Presse Med; 1991 Sep; 20(29):1374-83. PubMed ID: 1835012 [TBL] [Abstract][Full Text] [Related]